{
    "organizations": [],
    "uuid": "0614044bf33d26629c60469a44064e60f2b3ed43",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-allergan-says-fda-has-extended-uli/brief-allergan-says-fda-has-extended-ulipristal-acetate-nda-review-period-to-august-2018-idUSFWN1QI1L6",
    "ord_in_thread": 0,
    "title": "BRIEF-Allergan Says FDA Has Extended Ulipristal Acetate NDA Review Period To August 2018",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 28 (Reuters) - Allergan Plc:\n* ALLERGAN ANNOUNCES FDA HAS EXTENDED THE ULIPRISTAL ACETATE NDA REVIEW PERIOD TO AUGUST 2018\n* ALLERGAN PLC - PDUFA TARGET ACTION DATE HAS BEEN EXTENDED TO AUGUST 2018 TO PROVIDE TIME FOR A FULL REVIEW OF FILE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-01T05:36:00.000+02:00",
    "crawled": "2018-03-01T21:08:48.028+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "allergan",
        "plc",
        "allergan",
        "announces",
        "fda",
        "extended",
        "ulipristal",
        "acetate",
        "nda",
        "review",
        "period",
        "august",
        "allergan",
        "plc",
        "pdufa",
        "target",
        "action",
        "date",
        "extended",
        "august",
        "provide",
        "time",
        "full",
        "review",
        "file",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}